Basics Atea Pharmaceuticals, Inc. IPO Date: October 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $255.53M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 2.67% Avg Daily Range (30 D): $0.06 | 1.94% Avg Daily Range (90 D): $0.07 | 1.94% Institutional Daily Volume Avg Daily Volume: .69M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .3M Trade Size Avg Trade Size (Sh.): 117 Avg Trade Size (Sh.) (30 D): 108 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 743 Avg Inst. Trade: $1.95M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $.81M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.57M Avg Closing Trade (30 D): $.99M Avg Closing Trade (90 D): $.99M Avg Closing Volume: 183.51K     News Jul 31, 2025 @ 11:00 AM Atea Pharmaceuticals to Host Second Quarter 2025 F... Source: Atea Pharmaceuticals Jun 24, 2025 @ 11:00 AM Atea Pharmaceuticals Announces Continued Advanceme... Source: N/A Apr 23, 2025 @ 11:00 AM Atea Pharmaceuticals to Present New Data Showcasin... Source: N/A Apr 9, 2025 @ 11:00 AM Atea Pharmaceuticals Announces Dosing of First Pat... Source: N/A Mar 26, 2025 @ 5:58 PM Atea Pharmaceuticals Highlights Actions Underway t... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.62 $-.44 $-.4 Diluted EPS $-1.62 $-.44 $-.4 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -136.13M $ -37.16M $ -34.27M Operating Income / Loss $ -156.61M $ -41.35M $ -39.04M Cost of Revenue $ $ $ Net Cash Flow $ -155.67M $ -31.67M $ 54.7M PE Ratio     Splits Feb 14, 2018:   1:11